|
National Stock Number(NSN): 6505-01-323-2649 (6505013232649, 013232649)
| NIIN: |
01-323-2649 |
Item Name: |
CEFTAZIDIME SODIUM IN DEXTROSE INJECTION |
INC: |
46326
|
| FSC: |
6505
|
Assignment Date: |
Jul-26-1990 |
CRIT: |
X |
IIG: |
46326 |
| ISC: |
2 |
Date Standardized: |
Jul-26-1990 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Feb-26-2020 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
2G3536 |
04687
|
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES |
H |
5 |
2 |
4 |
KX |
|
|
|
|
|
|
|
2G558 |
93544
|
GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC. |
H |
5 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
90-0408 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
FORTAZ |
34006
|
GLAXO WELLCOME INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
FORTAZ INJECTION |
34006
|
GLAXO WELLCOME INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00173-0413-00 |
34006
|
GLAXO WELLCOME INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
F |
U |
1 |
A |
$708.43 |
PG |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
H |
|
F |
U |
1 |
F |
$708.43 |
PG |
|
------- |
Oct-01-2000 |
H |
| DN |
SMS |
Y |
|
F |
U |
1 |
N |
$708.43 |
PG |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
F |
U |
1 |
D |
$708.43 |
PG |
|
------- |
Dec-01-2000 |
H |
| VA |
JVS |
I |
|
0 |
U |
1 |
V |
$0.00 |
PG |
|
------- |
Apr-01-1993 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 24EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
FROZEN FOR PRESERVATION |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.0 GRAMS CEFTAZIDIME EQUIVALENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BAG WITH HANGING DEVICE, PLASTIC |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
50.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
24 |
| FEAT |
SPECIAL FEATURES |
1/6 GRAMS DEXTROSE,HYDROUS; SINGLE DOSE BAG WITH OUTLET PORT,MAY HAVE SECOND OUTLET PORT; IN OVER POUCH; FOR USE WITH DOD STOCK-LISTED IV ADMINISTRATION SETS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Feb-01-2004 |
3 |
Z |
|
|
54 |
54 |
|